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We previously described the presence of advanced oxidation protein products (AOPP), a novel marker of oxidative stress in the plasma of
hemodialyzed patients (HD). The present study was carried out to further investigate how myeloperoxidase (MPO)-catalyzed reactions could
contribute to AOPP generation in the plasma. First, patterns of plasma protein oxidation obtained after in vitro incubation of control plasma
with hypochlorous acid (HOCl) were compared to those from HD patients and control plasma. The use of various analytical techniques
enabled localising and identifying the main oxidized proteins with albumin (HSA) after protein separation by size-exclusion chromatography
and SDS-PAGE electrophoresis. The characterization of the oxidation level of the individual plasma proteins in terms of carbonyl groups and
3-nitrotyrosine formations was performed by immunoblotting. Secondly, to highlight the significance of AOPP index monitored by
spectrophotometry, spectra were established for plasma fractions from HD patients and compared to data for control plasma and HOCl-
treated plasma. The corresponding absorbance difference spectra were matched with external standards such as dityrosine, nitrotyrosine and
pentosidine and elaborated chromophoric probe models. Indeed, HSA was chlorinated by HOCl reagent or HOCl generated via the MPO/
H2O2/Cl
 system and was nitrated by tetranitromethane. Increased absorbances at the range of 340 nm were observed both with chlorinated
and nitrated HSA. Finally, our results indicate that HOCl, and not NO2
S
, generated via MPO activity, could represent one of the pathways for
AOPP production in plasma proteins exposed to activated phagocytes.
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1. Introduction idase (MPO) which catalyzes the reaction of chloride ionThe characterization of the specific oxidants responsible
for the modification of biomolecules in disease processes
has been challenging. Biomarkers of reactive oxygen spe-
cies reactions have the potential not only to determine the
extent of oxidative injury, but also to predict the potential
efficiency of therapeutic strategies aimed at reducing such
an oxidative stress. Activated phagocytes are a major source
of reactive oxidants and play a fundamental role in host
defense [1,2]. They contain the heme enzyme myeloperox-0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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(C. Capeille`re-Blandin).with hydrogen peroxide (H2O2) to generate large amounts of
hypochlorous acid (HOCl), a powerful oxidizing and chlo-
rinating agent produced by neutrophils [3,4]. Several recent
studies demonstrate that MPO also utilizes H2O2 and nitrite
(NO2
), the metabolic end product of NO, as substrates to
generate a microbicidal oxidant capable of nitrating pheno-
lic compounds and proteins in vitro [5–8]. Indeed, both
oxidative products react with a wide range of oxidizable
biomolecules and have been invoked as causing tissue
damage in a wide variety of unrelated pathologies [1,2,9].
In particular, it has been shown that HOCl-modified pro-
teins are present in atherosclerotic lesions [10,11] and
glomerular nephritis [12,13].
Oxidative stress has long been incriminated in the
development of the dialysis-related pathology. To estimate
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plasma of uremic patients, i.e. patients with chronic renal
failure and patients in maintenance dialysis therapy (HD),
the presence of advanced oxidation protein products
(AOPP) was investigated. We showed that in vivo plasma
levels of AOPP closely correlate with levels of dityrosine, a
hallmark of oxidized proteins and with pentosidine, a
marker of protein glycation closely related to oxidative
stress [14,15]. A new chromogen was found which caused
increased absorbance at 340 nm and its spectrophotometric
determination was proposed as a novel index of oxidative
stress measuring the level of AOPP [14]. Levels of AOPP
highly correlated with the creatinine clearance, thus reveal-
ing that AOPP were excellent markers of the progression of
chronic renal failure [14]. Interestingly, the significant
correlation between AOPP and neopterin, a marker of
macrophage activation, demonstrated that AOPP were
closely linked to phagocyte activation. In addition, in vitro,
HOCl-treated HSA and in vivo-generated AOPP were able
to trigger oxidative bursts in neutrophils as well as in
monocytes, thereby appearing to act as true inflammatory
mediators [16,17]. Regarding the AOPP generation mecha-
nism, in vitro studies pointed out that HOCl-treated HSA
was capable of triggering an oxidative burst [15].
The purpose of the present work was: (i) to provide new
data on the biochemical and molecular characteristics of
AOPP using a fast, reproductive and high performance se-
paration of plasma proteins; (ii) to document the mechanisms
leading to the formation of AOPP within plasma specially
focusing on MPO activities with chloride and nitrite ions;
(iii) to establish the contribution of the potential chromo-
phores in the spectrophotometric determination of AOPP.
The use of various analytical techniques enabled localising
and identifying the main oxidized proteins with HSA. To
interpret the spectral modifications detected in HD plasma
fractions, we described in detail some structural modifica-
tions that occur as a result of plasma or HSA treatment with
HOCl. Our results indicate that NO2
S
generated by MPO
activity is not implicated in AOPP production, whereas
HOCl may represent one of the pathways for AOPP produc-
tion in plasma proteins exposed to activated phagocytes.2. Materials and methods
2.1. Chemicals and reagents
Human serum albumin was purchased from Calbiochem-
Novabiochem Corp. Hydrogen peroxide, potassium iodide,
chloramine T and sodium hypochlorite were obtained from
Sigma Chemical Co. (St. Louis, MO, USA). Hydrogen
peroxide stock solutions were prepared by appropriate
dilutions of 30% H2O2 in deionized water. Their concen-
trations were determined spectrophotometrically (e240=43.6
M1 cm1) [18] and the required dilutions were made on a
daily basis. New solutions of HOCl/OCl (pKa=7.6) [19]were prepared by diluting commercial NaOCl in 10 mM
NaOH before use. In this report, the term HOCl will refer to
the sum of both species. The hypochlorite concentration was
determined spectrophotometrically at 292 nm (e=350 M1
cm1) after dilution with 10 mM NaOH [19]. All other
chemicals used were of the highest grade available and were
prepared daily in distilled deionized water. All experiments
were performed in 50 mM phosphate pH 7.4.
2.2. Blood collection and plasma isolation
In HD patients, blood was drawn from the fistula needle
just before the start of a hemodialysis session. In control
patients, venous blood (5–10 ml) was collected in standard
sterile polystyrene vacuum tubes, with 5 mM EDTA.
Following centrifugation (600g for 10 min) the plasma
was stored in 500 Al aliquots at 70 jC until use. Assays
were carried out on duplicate samples, which had been
thawed once.
2.3. Determination of AOPP equivalents
AOPP were determined in the plasma or in the fractions
using the semi-automated method previously devised in our
laboratory [14]. Briefly, AOPP are measured by spectro-
photometry on a microplate reader (Model MR 5000,
Dynatech, Paris, France), and are calibrated with chloramine
T solutions (Sigma) which in the presence of potassium
iodide absorb at 340 nm, thus defining an AOPP index [20].
2.4. Spectrophotometric analyses of AOPP
Absorbance spectra and repetitive scans were performed
using a Kontron Uvicon 930 spectrometer interfaced with a
computer making it possible to collect, manipulate and
analyze the data with the corresponding appropriate soft-
ware. Absorbance spectra were recorded from 500 to 200 nm
at 240 nm/min and 1 nm/point in a 1 cm light-path cuvette.
Plasma fractions of HD patients and controls were recorded
after a convenient dilution in 50 mM phosphate buffer pH
7.4 to obtain a maximum absorbance level at 280 nm below
1.2. Absorbance difference spectra between control and HD
plasma solutions or between control HSA and oxidized
HSA, normalized to the same absorbance at 280 nm, were
calculated and plotted using the Kaleidagraph V.3.08 pro-
gram. As the absorbance difference corresponded to the
added contribution of several chromophores, the experimen-
tal data were fit to spectra of known chromophores (tyrosine
derivatives, pentosidine) and adjusted to the desired height,
i.e. passing through the experimental data points.
2.5. Modification of HSA and control plasma with reagent
HOCl
The HSA (Calbiochem) concentration was measured by
absorbance at 280 nm (e=35 mM1 cm1) [21]. A 15 AM
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with various HOCl concentrations from 0.3 to 4 mM at 37
jC. The oxidation reaction was stopped using 1 mM
methionine and HSA was separated on a PD-10 Sephadex
column (Amersham Pharmacia). Plasma at the protein
concentration of 60 mg/ml was incubated with increasing
HOCl concentrations in the range of 4–100 mM. An
appropriate dialysis allows the removal of non-reactive
HOCl. Then the HOCl-treated plasma was fractioned by
molecular sieving.
2.6. MPO characteristics
MPO was purified from human polymorphonuclear neu-
trophils by sequential heparin-agarose affinity and anion-
exchange chromatographies as previously described in Ref.
[22]. The enzyme preparation used in this study exhibited a
purity index (A428/A279) equal to or higher than 0.81. The
MPO concentration, expressed as haem concentration, was
determined spectrophotometrically (e430=89 mM
1 cm1)
[23].
2.7. Oxidative treatment of HSA
When HSA was oxidized by the MPO system, to 15
AM HSA (1 mg/ml) in a 50 mM phosphate buffer pH 7.4
and 100 mM NaCl, 12 additions of 80 AM H2O2 were
made at 10-min intervals at 37 jC to ensure complete
conversion to HOCl. MPO 20 nM was added at the start
and subsequently at every second addition of H2O2. After
the final addition of H2O2, the sample was left for 1 h to
ensure that all the HOCl had reacted before the oxidation
reaction was stopped by using 1 mM methionine. Then
MPO-treated HSA was separated on a PD-10 Sephadex
column (Amersham Pharmacia).
2.8. Preparation of nitrated HSA
HSA nitration was performed by tetranitromethane
(TNM) treatment according to Ref. [24]. Briefly, HSA
in 50 mM phosphate buffer pH 7.4 was treated (1 h, 37
jC) with TNM at a 300 molar ratio (TNM/HSA).
Unreacted TNM and nitroformate were removed by ex-
haustive dialysis. Then, nitrated HSA (nitro-HSA) was
separated on a PD-10 Sephadex column (Amersham
Pharmacia). The 3-nitrotyrosine content was determined
spectrophotometrically using e430=4.2 mM
1 cm1 [25]
after making the solution alkaline with 2N NaOH. In the
two nitro-HSA samples prepared, the extent of nitration
was 6 and 12 mol nitrotyrosine/mol protein (or 30% and
65%), respectively.
2.9. Plasma fractioning
To achieve separations of AOPP bound to the plasma
proteins, a gel filtration was performed on a Superose 12HR 10/30 column adapted to a FPLC system (Amersham
Pharmacia). Aliquots of 0.5 ml of plasma 5-fold diluted in
50 mM phosphate buffer pH 7.4 were injected on to the
column equilibrated with the same buffer and eluted at a
flow rate of 0.3 ml/min. Detection was performed at 280
nm. To calibrate the column, the molecular protein standards
of Amersham Pharmacia containing blue dextran 2000
(2000 kDa), thyroglobulin (669 kDa), ferritin (440 kDa),
catalase (232 kDa), aldolase (158 kDa), albumin (67 kDa),
ovalbumin (45 kDa), chymotrypsinogen A (25 kDa) and
ribonuclease A (13.7 kDa) were used. After 30 runs, the 1
ml collected fractions gathered for identical elution volume
were pooled and concentrated 10 times by ultrafiltration on
Centricon Plus-20, PL-10 (Amicon). The resulting fractions
were kept frozen or used for spectral analyses and assayed
as detailed below.
2.10. Protein determination
Protein concentration was determined using the dye-
binding method of Bradford [26] with Coomassie Blue G-
250. A commercially available kit (Bio-Rad, Richmond, CA,
USA) was used with bovine serum albumin as a standard.
2.11. Molecular mass determination
Fractions containing AOPP activity were examined by
SDS-PAGE under denaturing and reducing conditions [27]
using a 12% polyacrylamide slab gel (13901.5 mm).
Samples of fractions and molecular mass standards were
diluted in Laemmli buffer and heated for 10 min at 95 jC.
Gels were developed with Coomassie blue procedures.
Colored molecular mass standards (Sigma) were used for
calibration.
2.12. Measurement of amino acid changes
2.12.1. Dityrosine measurement
Protein solutions were analyzed for the presence of
dityrosine by fluorescent measurements using a Kontron
SF 25 spectrophotometer. Aliquots of plasma fractions were
added to solutions of 20 mM phosphate buffer pH 7.5 in the
presence of 7 M urea [28]. After a 30-min incubation time,
the fluorescent emission spectra of dityrosine was recorded
from 550 to 350 nm following excitation at 320 nm.
Dityrosine has a characteristic emission spectrum with a
maximum at 410 nm. The assay was calibrated with
authentic dityrosine prepared using the HRP-catalyzed ox-
idation of tyrosine by H2O2 [29] described in Ref. [15] and
quantified using the extinction coefficient e315=4.5 mM
1
cm1 at pH 7.5.
2.12.2. Amino acid analysis
The amino acids composition of oxidized HSA was
established by M. Courteau at the Sequence Laboratory of
the Institut de Biologie et Chimie des Prote´ines (CNRS,
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containing a mixture of HCl 6N/TFA/thioglycolic acid (2V/
1V/5%) under a nitrogen flux. Acid hydrolysis of peptidic
bonds was carried out for 45 min at 150 jC in a Water Pico
Tag station. Samples were then dried under vacuum and
diluted in a Beckman buffer. Then, the amino acids were
separated on an ion exchange column and eluted with a
gradient of buffers, which differed in their ionic strength, pH
values and temperature. After elution, the amino acids were
revealed with ninhydrine at 135 jC and monitored at 570
nm, or at 440 nm for proline derivatives. Finally, the data
were analysed with Gold software.
2.12.3. Carbonyl content and nitrotyrosine formation by
immunoblots
These detections implied SDS-PAGE using 10% poly-
acrylamide gels and Western blotting. HOCl-treated HSA,
nitrated HSA and fractions of plasma protein samples were
run in a Bio-Rad miniprotean chamber as above. Proteins
were transferred to nitrocellulose membranes blocked in 2%
nonfat dry milk in PBS buffer. Carbonyl groups were
detected on oxidized proteins using OxyBlot Protein Oxi-
dation Kit (Intergen, Purchase, NY, USA). Proteins were
derivatized for 15 min with 2,4 dinitrophenylhydrazine
(DNP) in SDS and electrophoresed according to Laemmli.
After immunoblotting, a rabbit anti-DNP antibody (Inter-
gen) (dilution 1:1000) enabled the detection of carbonylFig. 1. Typical elution profiles of plasma proteins. Top panels: from left to right,
patient, and (C) control plasma incubated with 10 mM HOCl. Plasma was loaded o
rate was 0.3 ml/min. Bottom panels: fractions of 1 ml were collected to determine e
and 340 nm (squares), respectively, for (D) control plasma, (E) HD patient and (F)
molecular masses was indicated together with the corresponding fractions. Fraction
and five HOCl-treated plasma.groups derivatized with DNP. The binding antibody was
detected with a goat anti-rabbit IgG conjugated with HRP
(Amersham, UK) (dilution 1:2000). Bands were visualized
with chemo-luminescent chemicals and captured on films at
various exposure times. Detection of tyrosine nitration was
performed with an affinity-purified rabbit polyclonal IgG
antibody raised against peroxynitrite-treated LKH (keyhole
limpet haemocyanin) (Calbiochem, Darmstadt, Germany)
(dilution 1:1000). The binding antibody was detected using
a goat anti-rabbit IgG secondary antibody conjugated with
HRP (dilution 1:2000) and visualized by enhanced chemi-
luminescence. An in vitro nitrated sample of HSA was
analyzed at the same time. The colored molecular mass
standards (Sigma): a-lactalbumin (15 kDa), soybean trypsin
inhibitor (29 kDa), carbonic anhydrase (33 kDa), ovalbumin
(45 kDa), albumin (74 kDa), h-galactosidase (145 kDa) and
myosin (240 kDa) were used for calibration. Electrophoresis
results then presented were representative of experiments
performed three times.3. Results
3.1. Chromatographic properties of plasma proteins
To compare the molecular species present in control
plasma and in plasma from HD patients, a molecular sievingtypical elution profile of plasma proteins from (A) control plasma, (B) HD
n a Superose 12 equilibrated in 50 mM phosphate pH 7.4. The elution flow
lution volume and analyzed spectrophotometrically at 280 nm (solid circles)
control plasma incubated with 10 mM HOCl. Calibration of the column in
ation was performed on eight HD plasma and compared with eight controls
Fig. 2. SDS-PAGE comparison of typical elution profiles of control plasma,
HD plasma and HOCl-treated plasma. The polypeptide components of each
eluted fraction obtained by molecular sieving of plasma proteins were
determined by electrophoresis on 12% (w/v) polyacrylamide gel run
essentially according to Laemmli and stained with Coomassie blue.
Samples were diluted in Laemmli buffer containing 5% h-mercaptoethanol
and 2% SDS and denatured by heating at 95 jC. On the left, the first lane
contains the colored molecular mass standards (Sigma). The position of
HSA is indicated by an arrow. Whatever the plasma considered, fractions
from 9 to 14 were subjected to electrophoresis using a 30 Ag of protein per
lane, fractions 8 and 15 were at 10 Ag per lane. (A) Fractions from control
plasma, (B) fractions from HD plasma, (C) fractions from HOCl-treated
plasma.
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raphy on a Superose 12 column in line with a FPLC system
which achieved a fast, reproductive and automatic recycling
for these routine preparative purposes (Fig. 1, upper panels).
When elution volumes were compared with those of stan-
dard proteins, three major peaks were detected at 670, 170
and 71 kDa in the plasma of both control (Fig. 1A) and HD
patients (Fig. 1B) in fractions 8, 12 and 13, respectively,
thus, confirming our previous data obtained with a low-
pressure system [14]. Furthermore, in the present study, a
quantitative analysis of the peak area showed that the peak
at 670 kDa was twice as high in HD than in control plasma,
indicating a significant aggregation of the proteins in HD
patients. This observation has been confirmed by comparing
the peak area, which had a ratio of 0.5, 0.5, 1, respectively
in HD plasma versus 0.25, 0.5, 1 in the control plasma. To
provide some insights into the in vivo formation mecha-
nisms of oxidized proteins in HD plasma catalyzed by the
activity of MPO, the molecular masses distribution of
control plasma incubated with increasing HOCl concentra-
tions were established by FPLC (Fig. 1C). Typically, oxi-
datively modified plasma by 10 mM HOCl showed a FPLC
gel-filtration profile closely resembling that of HD patients
with peak areas at 670, 170, and 71 kDa in a ratio of 0.7,
0.6, and 1, respectively.
For each fraction, the absorbance spectrum was recorded
and protein concentration and AOPP content, expressed by
absorbance at 280 and 340 nm, respectively, were deter-
mined (Fig. 1, lower panels). The AOPP detection followed
the protein peaks in the plasma from HD, with a high level
collected in fraction 13 at 71 kDa, representing mainly
native HSA (Fig. 1E). In contrast, no obvious peaks of
AOPP could be detected in any fraction of control plasma
(Fig. 1D). Spectrophotometric determinations underlined
that the mobility and size of the native proteins were altered
by HOCl oxidation as showed by the increase in high
molecular weight proteins (fractions 8–11) associated with
high AOPP levels as in HD patients (Fig. 1F). As expected,
a linear correlation (R2=0.93) was obtained between the
maximum absorbance determined at 280 nm and the protein
concentration measured by colorimetric reaction. Moreover,
for HD plasma fractions, a linear correlation was still
obtained between A340 determined on the spectrophotometer
and the AOPP index (R2=0.91) (data not shown), thus,
suggesting a direct and valuable verification of the presence
of AOPP by spectrophotometry using a 1 cm light-path
cuvette. This set of data demonstrated the reliability of the
microtiter plate reader in the clinical evaluation of plasma
AOPP as first described by us [14] and confirmed by others
[30–32].
3.2. SDS-PAGE analyses of protein fractions
SDS-PAGE analysis was performed to describe the
polypeptide components of the elution pattern of control
plasma and HD plasma. Under denaturing and reducingconditions, protein aggregates became dissociated and
soluble as shown in high-molecular mass proteins fractions
8–10 from control plasma (Fig. 2A). In contrast, fraction
8 from HD, associated with a high AOPP level, showed a
diffused smear, corresponding to high molecular mass
covalent aggregates which were stable to reduction and
which expanded over 98–240 kDa, presumably as a result
of cross-linking (Fig. 2B). The major differences in the
patterns were found in fractions numbered 11–14, which
contained AOPP in HD fractions. In control plasma frac-
tions, a single band at around 67 kDa, which corresponds
Fig. 3. Immunoblots analysis for protein-bound carbonyl groups. Fractions
from 8 to 15 of plasma protein collected from Superose 12 chromatography
were derivatized with DNP and applied to the gel at 5 Ag per lane for
electrophoresis and Western blotting. On the left, the migration of colored
molecular mass standards (Sigma) are indicated in kDa. The position of
HSA is indicated by an arrow. From top to bottom: fractions 8–15 from (A)
control plasma, (B) HD plasma and (C) HOCl-treated plasma.
Fig. 4. Immunoblot analysis for protein-bound nitrotyrosine. (A) Compar-
ative reactivity of the polyclonal anti-nitrotyrosine antibody with, from left
to right, HSA applied at 5 Ag per lane, 30% and 65% nitrated HSA applied
at 1 Ag per lane and HOCl-treated HSA by 10 and 75 mM HOCl applied at
5 Ag per lane. Lower panels (B) and (C): from left to right, fractions 8–15
of plasma protein collected from Superose 12 chromatography were applied
at 5 Ag per lane, electrophoresed on 10% polyacrylamide gels and
immunoblotted using rabbit polyclonal antibody that recognized 3-
nitrotyrosine and detected by chemiluminescence; lane labelled «+»
contained a positive control, 30% nitrated HSA. (B) Fractions from control
plasma, (C) fractions from HD plasma. On the left, the migration of the
colored molecular mass standards (Sigma) are indicated in kDa. The
position of HSA is indicated by an arrow.
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revealed the presence of a larger band of g globulin heavy
chain at 52 kDa associated with albumin at 67 kDa. An
additional band at 80 kDa (a–h globulin) could be
detected together with a dimeric form of albumin at 116
kDa in HD fractions 12, 13 and 14 and not in corre-
sponding control fractions. In conclusion, the comparison
of the patterns observed in HD fractions and control
fractions underlines that plasma AOPP result from the
association of several oxidized proteins, including HSA
and gamma globulins.
After exposure to HOCl (Fig. 2C), protein aggregation or
cross-linking was clearly evident by the presence of a smear
in the high molecular range in fractions 8–10. Interestingly,
one single band at 67 kDa was detected in fractions 12–14
with a significant increase in protein staining in fractions 13
and 14. These data showed that AOPP, generated in vivo
and detected in HD fractions, have polypeptide components
different from those induced in HOCl-treated plasma, thus,
suggesting that the in vivo mechanisms of AOPP generation
include but are not restricted to the HOCl action.3.3. Evaluation of oxidation extent
3.3.1. Dityrosine formation
Previously, we showed that dityrosine production was a
useful marker for the presence of protein oxidation in HD
plasma [14]. A close correlation between AOPP (Amol/l)
and dityrosine levels (nmol/mg protein) in HOCl-treated
HSA have been reported. In the present study, the correla-
tion was confirmed between dityrosine levels determined by
fluorescence measurements, and AOPP levels measured by
absorbance at 340 nm in fractions 12–14 of several HD
patients (data not shown). Dityrosine contents determined in
these HD fraction were scattered from 0.4 to 1.1 nmol of
dityrosine per mg protein with absorbance at 340 nm in the
range of 0.03–0.2. When a standard curve was established
with HOCl-treated HSA samples of known dityrosine con-
tent, the mean value at 0.7 nmol DT/mg protein for HD
fraction would correspond to the effect of a 30-min incu-
bation time with HOCl at a relatively low molar ratio, i.e. 35
HOCl/HSA molar ratio.
Biophysica Acta 1689 (2004) 91–102
Table 1
Changes in amino acids composition of HSA treated with HOCl
Amino
acids
Literature
valuea
Control HSAb
(n=2)
HOCl/HSA=67c
(n=2)
Aspd 36 53.6F0.1 57.6F0.3
Thr 28 23.7F0.3 24.8F0.4
Ser 24 21.8F0.4 22.3F0.3
Glue 62 84.8F0.2 90.2F0.3
Pro 24 47.5F0.4 47.3F0.3
Gly 12 12.7F0.4 13.3F0.4
Ala 62 61.1F0.2 64F0.4
Val 41 30F0.1 32.4F0.2
Met 6 6.1F0.2 2.6F0.4
Ile 8 4.2F0.1 4.5F0.2
Leu 61 66F0.4 70.4F0.4
Tyr 18 15.5F0.1 6.5F0.4
Phe 31 29.3F0.1 31.1F0.6
His 16 14.1F0.1 19.4F0.4
Lys 59 53.0F0.3 36.2F0.4
Arg 24 23.3F0.1 23.5F0.2
Amino acid compositions of control and HOCl-modified HSA determined
from acid hydrolytic procedures described in Materials and methods.
ValuesFS.D. are means of n independent determinations.
a Values deduced from known amino acid composition of HSA obtained
from GenBank (accession number A06977).
b Values obtained for native HSA.
c Values obtained for HSA treated by a 67 HOCl/HSA molar ratio for
30 min at 37 jC.
d Includes asparagine residues.
e
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The extent of carbonyl-modified proteins was assessed
by a Western blot immunoassay performed on FPLC plasma
Includes glutamine residues.Fig. 5. Spectral changes in HSA and control plasma treated with chlorinated oxid
treated by the MPO, H2O2 and chloride system were recorded and normalized fo
reagent for 30 min at 37 jC, or by the MPO/H2O2/Cl
 system generating at mos
absorbance difference spectra were established for HSA treated with chlorinated o
native HSA. The difference spectrum was calculated between fraction 13 of a co
fraction 13 of the untreated control plasma (line c).fractions. In control plasma, no significant band was
revealed using anti-DNP detection in any fraction (Fig.
3A). In contrast, HD fraction 11–12–13–14 displayed
protein bands of molecular masses centered on 67 kDa with
an intense anti-DNP signal (Fig. 3B), indicating increased
carbonyl content. However, less carbonyl staining was
found in association with fraction 8, although it was
associated with a high AOPP level. These results confirmed
the presence of a high level of oxidized proteins in HD
plasma as compared to controls. Exposure of plasma to 10
mM HOCl (Fig. 3C) generated a significant increase in anti-
DNP signals from protein of molecular masses 67 and 52
kDa, regardless of the fraction considered. These data
underlined that carbonyl-modified proteins are restricted to
specific HD fractions containing AOPP levels, whereas
HOCl treatment of plasma led to carbonyl formation wide-
spread over the whole pattern. Thus, these data enabled to
conclude that anti-DNP detection is a likely approach to
reveal differences between in vivo AOPP and those gener-
ated by HOCl treatment.
3.3.3. Determination of nitrotyrosine in plasma fractions
Western blot analysis of nitrotyrosine was first standard-
ized using HSA submitted to TNM treatment to generate
nitrotyrosine as described in Materials and methods. Fig. 4A
demonstrates that the antibody anti-nitrotyrosine reacts with
HSA-nitrotyrosine and that this reactivity is dependent on
the dose of TNM used for nitrotyrosine synthesis and thus
on the amount of nitrotyrosine generated on HSA. However,
HSA and HOCl-treated HSA did not react with the nitro-ants. Absorbance spectra of the native HSA, HOCl-treated HSA and HSA
r protein content at 280 nm. HSA (15 AM) was treated by 0.4 mM HOCl
t 960 AM HOCl as described in Materials and methods. The corresponding
xidants (HOCl reagent line a; MPO/H2O2/Cl
 system line b), compared to
ntrol plasma previously treated by 10 mM HOCl for 30 min at 37 jC and
C. Capeille`re-Blandin et al. / Biochimica et Biophysica Acta 1689 (2004) 91–10298tyrosine antibody (Fig. 4A). Interestingly, Western blot
analyses of the whole pattern of plasma fractions revealed
that nitrotyrosine-associated proteins could be detected in
fractions 13–15, at the level of 67 kDa, both in controls and
HD plasma (Fig. 4B,C). These data showed that AOPP was
not related to nitrotyrosine formation.
3.4. Amino acid analysis
In order to specify which other amino acids could be
implicated in reactions with 10 mM HOCl, a complete
analysis of the HSA amino acid composition was carriedFig. 6. Absorbance spectra of plasma protein fractions eluted at the albumin positio
different donors, named HD1, HD2, HD3, HD4, were recorded from 500 to 200 n
450 to 290 nm showing absorbance increase in HD plasma fraction 13 with differ
0.107, 0.165 for HD1, HD2, HD3 and HD4, respectively) as compared to control
illustrated above and calculated between spectra of fraction 13 in various HD plaout and the results are presented in Table 1. We first verified
that the values obtained for a native HSA of 585 amino
acids were in line with the sequence and amino acid
composition obtained from GenBank (access number
A06977). Data showed that an exposure to HOCl induced
a change in the content of some specific amino acids:
positively charged amino acids lysine and histidine, tyrosine
and methionine. This composition confirmed the loss of
tyrosine residues, suggested by the loss of fluorescent
emission at 350 nm after excitation at 280 nm [15], and
the expected modification of the methionine residue, known
to be one of the amino acids which reacts the most rapidlyn. The absorbance spectra of fraction 13 from control and HD plasma from
m and normalized for protein content at 280 nm. (A) Zoomed Y-scale from
ent AOPP content determined with a microplate reader (A340 nm=0.45, 0.74,
plasma (A340 nm=0). (B) Absorbance difference spectra deduced from data
sma and control plasma.
C. Capeille`re-Blandin et al. / Biochimica etwith HOCl [33,34]. It was observed that 3-chlorotyrosine, a
possible product of the reaction of tyrosine chlorination by
HOCl, eluted at the same retention time as histidine and
therefore could not be quantified. Aliphatic amino acids and
hydroxy amino acids were not significantly modified. All
these results demonstrate that the presence of HOCl results
in a selective modification of some specific protein amino
acids.
3.5. Spectral properties of in vitro model systems
Since plasma proteins were found nitrated by Western
blotting, spectra of nitrated-HSA were first investigated.
At pH 7.4, two peaks at 436 and 361 nm were detected
as compared to native HSA. They disappeared with
reduction by dithionite, which reduces nitrotyrosine to
colorless aminotyrosine. With an increase in pH, the
maximum absorbance shifted from 360 to 430 nm,
characteristic of the presence of nitrotyrosine [24,25] (data
not shown).
Since chlorinated oxidants appeared to be the most
efficient for inducing AOPP in HSA [15], we further studied
spectral characteristics of HOCl-induced AOPP in control
plasma fractions and HSA, compared to those of untreated
plasma fractions and native HSA. As shown in Fig. 5 (lines
a and b), the peak difference between native and modified
HSA solutions obtained by incubation with HOCl or with
the MPO/H2O2/Cl
 system occurred at 310 nm and
appeared to be the feature of HSA treated with chlorinated
oxidants. Interestingly, a similar absorbance difference
spectrum is observed in fraction 13 of plasma treated with
HOCl (Fig. 5, line c).Fig. 7. Spectral changes associated with AOPP in HD plasma fractions. Spectra ob
by HOCl treatment of control plasma. Difference spectra of HOCl-treated plasma
different AOPP content (HD1, HD2, HD3 and HD4) (Fig. 6B) after normalization
(crosses), with maximal absorbance at 337 nm, fitted the HD4 data.3.6. Spectral properties of HD plasma protein fractions
Absorbance spectra in the range 500–200 nm were
recorded on fractions eluted from FPLC and containing
high levels of AOPP. Spectral analyses of the absorbance
spectra of HD fraction 13, eluting at the albumin position
and containing AOPP, showed that the absorbance was
significantly increased between 300 and 450 nm compared
with normal plasma fractions (Fig. 6A). To quantify these
differences, absorbance difference spectra between HD
fractions and corresponding fractions in control plasma were
established. As shown in Fig. 6B, the peak difference
occurred at approximately 310 nm and, to a lesser extent,
at 340 nm, thus underlining the spectral contribution of
several chromophores associated with AOPP. Of note, these
spectral changes were not modified on acidification or
alcalinisation and in the presence of dithionite.
The absorbance difference spectra established for HD
plasma fraction 13 were globally corrected for the contri-
bution of AOPP generated by HOCl by subtraction of the
data obtained for HOCl-treated plasma in the corresponding
fraction (Fig. 5, line c). The results are presented in Fig. 7
for different HD patients and show that the absorbance
intensity detected at 340 nm is correlated to the AOPP
content. In the search of a potential candidate chromophore
to account for the resulting absorbance band at 340 nm
pentosidine has been put forward. Previously, we showed
that the levels of AGE-pentosidine and AOPP were corre-
lated in plasma from HD patients [15]. We therefore
suggested that AGE-pentosidine and AOPP may share
common structural and/or spectrophotometric features. In-
terestingly, the spectrum of pentosidine has a band centered
Biophysica Acta 1689 (2004) 91–102 99tained when corrections were made for the contribution of AOPP generated
(Fig. 5, line c) was subtracted from difference spectra of HD fractions with
to the same height at 310 nm. The spectrum of a 40 AM pentosidine solution
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fraction (Fig. 7). Therefore, the absorbance of pentosidine
may contribute to AOPP measurements.4. Discussion
The present study was aimed at providing new advances
in the molecular species and spectral properties of AOPP
present in high levels in plasma of HD patients. Our data
show that AOPP are MPO-mediated oxidized HSA. Elution
patterns obtained after plasma fractioning by a novel and
reproductive FPLC of HD plasma provided a correlation
between two peaks of AOPP and two distinct molecular
species centered at 670 and 71 kDa. Parallel SDS-PAGE
showed that HSA and globulins matched the low molecular
mass AOPP peak, while the high molecular mass AOPP
peak is mostly due to aggregates of HSA likely resulting
from disulfide bridges and/or dityrosine cross-linking. Thiol
groups of HSA are known to account for the major
antioxidant capacity of normal human plasma [35,36].
Indeed, data from the HSA protein model studied in the
present work showed a decrease in methionine residues
upon HOCl treatment, which is known to react as equally as
cysteine [33,34,37]. Thus, evidence of aggregation was
likely to be attributed to new intermolecular covalent bonds.
This is consistent with the dityrosine detection, which can
account for subunit cross-linking and higher molecular mass
complexes on reducing gels [28,38–41].
An elution pattern similar to AOPP peaks was obtained
after treatment of normal plasma by HOCl. In fractions 12,
13, and 14 associated with AOPP, a single band of HSAwas
found associated with protein carbonyls, thus, confirming
that HSA was the major target for HOCl oxidation. In
contrast, differences in the whole pattern were noticed in
the molecular composition and carbonyl distribution in HD
and HOCl-treated plasma fractions. Taken together, these
results provide strong proof that AOPP correspond to highly
oxidized proteins and specifically to HSA, however, the in
vivo mechanisms of AOPP generation is not restricted to a
HOCl reaction.
Interestingly, when purified HSA was used as a model
protein to investigate the modifications in plasma proteins
by chlorinated oxidants, the HOCl treatment mediated
attacks on lysine residues known to form chloramine [42].
In our previous studies on HD plasma, chloramines were not
detected [14]. Presently, protein carbonyl groups were
detected in plasma fractions, thus in agreement with pub-
lished reports [43,44] showing that chloramines are slowly
hydrolyzed into aldehydes, thus increasing the pool of
detected carbonyl groups.
Of interest, plasma protein carbonyl formation could be
induced by peroxynitrite and nitrating agents generated
through MPO activity [5,9]. The presence of 3-nitrotyrosine
is a selective marker of nitration in biological fluids [45]. In
the present study, we did not observe a significant differencein nitrotyrosine distribution in HD plasma fractions 12–14
compared to normal plasma fractions, as detected by West-
ern blotting. This finding made it possible to conclude a
relatively greater involvement of the MPO/H2O2/Cl
 sys-
tem compared to that of MPO/H2O2/nitrite in forming
AOPP in HD plasma proteins in vivo. This conclusion
was supported by spectrophotometric investigations of plas-
ma fractions which demonstrated the absence of effect due
to pH variations and addition of dithionite on the spectral
changes detected in HD plasma fractions 12–14 and in
fractions from HOCl-treated plasma, compared to those of
nitrated HSA.
We previously reported that AOPP can be quantified by
absorbance measurements at 340 nm, thus defining a novel
marker of oxidative damage [14]. To further investigate the
significance of these absorbance changes, spectrophotomet-
ric studies on plasma fractions first underlined, the over-
lapping of two chromophoric bands with maxima at 310 and
340 nm detected in the difference absorbance spectra of HD
plasma fractions. Secondly, content modifications or char-
acteristics of chromophores were induced by chlorinated
oxidants. A decrease in tyrosine residues was noticed upon
HOCl treatment of HSA. These results agree with published
reports on chlorination reactions in proteins involving the
formations of 3-chlorotyrosine [46,47], 3,5-dichlorotyrosine
[48] and dityrosine [39], which all are known to absorb in a
range of 280–320 nm in the phenoxide state. Indeed, HOCl-
modified proteins were detected in early and acute stages of
inflammation, e.g. glomerular defects [13,49]. Finally, data
support the conclusion that the chromophore at 310 nm
could be related to the presence of modified tyrosines
induced by the activity of MPO in the presence of H2O2
and chloride.
An interesting finding in the present study is that, when
the AOPP spectral contribution generated by HOCl was
taken into account, the corresponding spectrum revealed an
absorbance maximum at 340 nm matching the spectrum of
pentosidine. In a previous study [15], the close correlation
observed between plasma AGE-pentosidine and AOPP
suggested that AGE and AOPP may share a common
formation mechanism and/or common biological activities
in vivo. Indeed, published reports pointed out the involve-
ment of oxidative pathways in the formation of AGE in
patients with end-stage renal failure [50,51]. Finally, AOPP
are mainly associated with oxidized HSA and dependent on
MPO chlorination activities, but not exclusively, since their
quantitation also involve detecting pentosidine, a molecule
which results from crosslinks in proteins between arginine
and lysine via oxidized glucose.
Our final goal was to validate the AOPP determination as
a sensitive, accurate and surrogate marker for MPO-derived
oxidative stress which could be useful in clinical applica-
tions. In this report, we demonstrated that the method for
AOPP measurement using a microtiter plate reader, which
we have previously devised in our laboratory, is as reliable
as the method based on a conventional spectrophotometer
C. Capeille`re-Blandin et al. / Biochimica et Biophysica Acta 1689 (2004) 91–102 101with a 1 cm light-path cuvette. Therefore, AOPP could be
determined routinely using a simple protocol to investigate
MPO-induced oxidative stress. It should be noted that
several other groups have successfully determined AOPP
and considered AOPP as a potential useful marker for
clinical purposes. The relevance of AOPP in chronic renal
failure has been confirmed by several groups [17,32,52–
54]. We and others, have demonstrated the importance of
AOPP in coronary artery disease [31,55]. AOPP have also
been investigated in the field of diabetes [56], preterm
neonates [57] and dendritic cell stimulation [30].
In conclusion, the present work showed: (i) that AOPP
result from MPO-derived oxidative stress, but not exclu-
sively; (ii) that the spectral characteristics of AOPP corre-
spond to several chromophores which include dityrosine,
carbonyls and pentosidine but not nitrotyrosine; (iii) that
AOPP could be routinely measured using our previously
devised method for clinical investigations.Acknowledgements
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